May is National Brain Tumor Awareness Month. Driven by advancement in research, surgical techniques, genetic discoveries, and much more, it has never been a better time to take action on brain tumors. The National Brain Tumor Society (NBTS), an organization whose mission is to unrelentingly invest in, mobilize, and unite our community to discover a […]
Two student authors from Philadelphia CyberKnife presented at the Philadelphia Society of Oncology and Hematology’s annual scientific meeting from October 2 – 3 in Lafayette Hill, Pennsylvania. The Pennsylvania Society of Oncology and Hematology (PSOH) is a non-profit corporation devoted to the improvement of hematologic and oncologic care of patients. Membership in the organization includes […]
Philadelphia magazine continued their healthcare series about the CyberKnife® Robotic Radiosurgery System with a second online blog post about the new medical treatment that’s changing the way local doctors approach cancer. The blog listed several types of cancers that CyberKnife treats (brain, lung, pancreas, spine, kidney and liver), but mainly focused on prostate cancer, one […]
Philadelphia CyberKnife presented three clinical outcomes research projects at the American College of Radiation Oncology’s 25th annual meeting from May 14 – 16 in Washington, D.C. American College of Radiation Oncology (ACRO) is the essential professional society for success in the day-to-day practice of radiation oncology. ACRO strives to ensure the highest quality care for […]
This month, Philadelphia CyberKnife celebrates its seventh year of operations as a service of Delaware County Memorial Hospital, part of the Crozer-Keystone Health System. Our center was the first provider of stereotactic radiosurgery (SRS) treatment in the Philadelphia region, and we’ve treated nearly 2,000 patients with the advanced procedure using CyberKnife® technology. Through research spearheaded […]
Dr. John Lamond, associate medical director of Philadelphia CyberKnife, has more than 20 years of experience treating tumors throughout the body. As an active clinical researcher, Dr. Lamond has special interests in brain and lung cancers and has served as the principal investigator on several studies. Read about results from a recent study he co-authored […]
Newly published research from Philadelphia CyberKnife provides some of the most convincing evidence yet that stereotactic body radiation therapy is among the most effective types of treatment for prostate cancer.
Authors say that, while more follow-up is needed, the study shows SBRT’s success rate is comparable to other treatments, including conventional surgery, which is often held as the gold standard treatment for prostate cancer. In addition, SBRT offered more convenient treatment and less risk of side effects like erectile dysfunction.
“Radiation oncologists believe the results with SBRT are equivalent to what you’d get from surgery or other forms of radiation, but there’s never been a head-to-head comparison,” says Dr. Rachelle Lanciano, chief of radiation oncology at Delaware County Memorial Hospital, who co-wrote the study. “This is another piece of the puzzle showing that SBRT works, the toxicity is low, and the outcomes are very good.”
Philadelphia CyberKnife physicians are set this week to present innovative research findings demonstrating the effectiveness of stereotactic body radiation therapy for treating primary and recurrent lung cancer.
Two studies will be presented Feb. 22 at the Radiosurgery Society’s 2013 SRS/SBRT Scientific Meeting in California. These are the latest studies from Philadelphia CyberKnife, which has carved a niche for trailblazing clinical research focused on stereotactic body radiation therapy. CyberKnife® is a robotic technology that provides stereotactic body radiation therapy, or SBRT, a noninvasive method of treating tumors with very precise, high-dose radiation beams in five or fewer procedures.
According to the American Cancer Society, brain tumors account for one in every 100 cancers diagnosed annually in the United States. CyberKnife® stereotactic radiosurgery is an advanced treatment option for brain tumors, providing an important nonsurgical alternative for patients. Below is a brief overview of brain tumors, incidence rates and treatment options. The information provided […]